Circulating cancer cells—and in particular their very rare subpopulation, circulating cancer stem cells (cCSCs)—are responsible for recurrence and metastasis. In this study, we present a novel process in which patient-derived xenograft (PDX) can be harve https://t.co/cy15vVLmD2
@LibbyMbc@MammaMiaMagazin Its way more effective to assign the right existing drugs to the patient. And insurances can pay for performance. This is the way we do it. https://t.co/nwaZTlosxJ